Cart
sales@molnova.com
E4CPG
CAS No. 170846-89-6
E4CPG ( —— )
Catalog No. M17366 CAS No. 170846-89-6
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | Get Quote |
|
| 5MG | 58 | Get Quote |
|
| 10MG | 80 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 339 | Get Quote |
|
| 100MG | 503 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameE4CPG
-
NoteResearch use only, not for human use.
-
Brief DescriptionE4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
-
DescriptionE4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptormGluR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number170846-89-6
-
Formula Weight223.23
-
Molecular FormulaC11H13NO4
-
Purity98%
-
SolubilityDMSO : < 1 mg/mL
-
SMILESC(=O)(c1ccc(cc1)C(CC)(C(=O)O)N)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sekiyama N et al. Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptorsubtypes. Br J Pharmacol, 1996 Apr, 117(7):1493-503.
molnova catalog
related products
-
PD173074
PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM in cell-free assays, ~1000-fold selective for FGFR1 than PDGFR and c-Src.
-
AZD-9291 mesylate
A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.
-
WHI-P258
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
